Cargando…
Synthesizing Molecular and Immune Characteristics to Move Beyond WHO Grade in Meningiomas: A Focused Review
No portion of this manuscript has previously been presented. Meningiomas, the most common primary intracranial tumors, are histologically categorized by the World Health Organization (WHO) grading system. While higher WHO grade is generally associated with poor clinical outcomes, a significant subse...
Autores principales: | Kannapadi, Nivedha V., Shah, Pavan P., Mathios, Dimitrios, Jackson, Christopher M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9194503/ https://www.ncbi.nlm.nih.gov/pubmed/35712492 http://dx.doi.org/10.3389/fonc.2022.892004 |
Ejemplares similares
-
Radiation Treatment for WHO Grade II and III Meningiomas
por: Walcott, Brian P., et al.
Publicado: (2013) -
The efficacy of preoperative MRI features in the diagnosis of meningioma WHO grade and brain invasion
por: Jiang, Jun, et al.
Publicado: (2023) -
The Discrepancy Between Standard Histologic WHO Grading of Meningioma and Molecular Profile: A Single Institution Series
por: Roehrkasse, Amanda M., et al.
Publicado: (2022) -
High Tumor Mitochondrial DNA Content Correlates With an Improved Patient's Outcome in WHO Grade III Meningioma
por: Hua, Lingyang, et al.
Publicado: (2020) -
Whole-Exome Sequencing Reveals Recurrent but Heterogeneous Mutational Profiles in Sporadic WHO Grade 1 Meningiomas
por: González-Tablas, María, et al.
Publicado: (2021)